Login
Super Investors Kresge Foundation
KF

Kresge Foundation

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
—
Positions
1
Quarter ended
December 31, 2019
Filed
February 28, 2020

Reported portfolio value by quarter (5 quarters reported)

$48.9M —
Q4 18 Q1 19 Q2 19 Q3 19 Q4 19

$48.9M in Q4 2018 → — now. Hover for any quarter.

Holdings

As reported for the quarter ended December 31, 2019. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
0 0 NaN% Unchanged 0 —

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 4 quarters.

Q4 2019

quarter ended December 31, 2019 · filed February 28, 2020

No position changes this quarter.

Q3 2019

quarter ended September 30, 2019 · filed December 04, 2019

No position changes this quarter.

Q2 2019

quarter ended June 30, 2019 · filed August 29, 2019

No position changes this quarter.

Q1 2019

quarter ended March 31, 2019 · filed May 16, 2019

Company Action Shares changed Value of change % of portfolio
C Cigna Corp Exited −63,284 −$12.1M —
Iqvia Holdings Inc Exited −84,000 −$9.68M —
Centene Corp Exited −43,407 −$4.99M —
Micron Technology Inc Exited −142,000 −$4.51M —
FN F5 Networks Inc Exited −27,000 −$4.37M —
Adobe Inc Exited −15,000 −$3.39M —
CD Cadence Design Sys Inc Exited −58,000 −$2.52M —
Nektar Therapeutics Exited −62,000 −$2.01M —
CR Charles River Laboratories Exited −16,000 −$1.8M —
MK Michael Kors Holdings Ltd Exited −45,000 −$1.7M —

Showing the 10 largest of 13 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support